BridgeBio Pharma, Inc. Costs and Expenses in USD from 2019 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Total costs of sales and operating expenses for the period.
Summary
BridgeBio Pharma, Inc. quarterly/annual Costs and Expenses history and growth rate from 2019 to Q3 2025.
  • BridgeBio Pharma, Inc. Costs and Expenses for the quarter ending September 30, 2025 was $266M, a 36.7% increase year-over-year.
  • BridgeBio Pharma, Inc. Costs and Expenses for the twelve months ending September 30, 2025 was $964M, a 26.4% increase year-over-year.
  • BridgeBio Pharma, Inc. annual Costs and Expenses for 2024 was $815M, a 32.1% increase from 2023.
  • BridgeBio Pharma, Inc. annual Costs and Expenses for 2023 was $617M, a 4.55% increase from 2022.
  • BridgeBio Pharma, Inc. annual Costs and Expenses for 2022 was $590M, a 8.74% decline from 2021.
Costs and Expenses, Trailing 12 Months (USD)
Costs and Expenses, Quarterly (USD)
Costs and Expenses, YoY Quarterly Growth (%)
Costs and Expenses, Annual (USD)
Costs and Expenses, YoY Annual Growth (%)

BridgeBio Pharma, Inc. Quarterly Costs and Expenses (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 $964M $266M +$71.4M +36.7% Jul 1, 2025 Sep 30, 2025 10-Q 2025-10-29
Q2 2025 $892M $245M +$67.1M +37.8% Apr 1, 2025 Jun 30, 2025 10-Q 2025-08-05
Q1 2025 $825M $221M +$10.2M +4.85% Jan 1, 2025 Mar 31, 2025 10-Q 2025-04-29
Q4 2024 $815M $232M +$52.7M +29.4% Oct 1, 2024 Dec 31, 2024 10-K 2025-02-20
Q3 2024 $762M $194M +$32.7M +20.2% Jul 1, 2024 Sep 30, 2024 10-Q 2025-10-29
Q2 2024 $729M $178M +$30M +20.3% Apr 1, 2024 Jun 30, 2024 10-Q 2025-08-05
Q1 2024 $699M $211M +$82.8M +64.7% Jan 1, 2024 Mar 31, 2024 10-Q 2025-04-29
Q4 2023 $617M $179M +$48.1M +36.7% Oct 1, 2023 Dec 31, 2023 10-K 2025-02-20
Q3 2023 $569M $162M +$32.3M +25% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-12
Q2 2023 $536M $148M -$6.18M -4.02% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-01
Q1 2023 $542M $128M -$47.4M -27% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-02
Q4 2022 $590M $131M -$47.4M -26.6% Oct 1, 2022 Dec 31, 2022 10-K 2025-02-20
Q3 2022 $637M $129M -$22.4M -14.7% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-02
Q2 2022 $660M $154M +$5.88M +3.97% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-03
Q1 2022 $654M $175M +$7.41M +4.41% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-04
Q4 2021 $646M $179M Oct 1, 2021 Dec 31, 2021 10-K 2024-02-22
Q3 2021 $152M +$23.8M +18.6% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 $148M +$23.5M +18.8% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-04
Q1 2021 $168M Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-05
Q3 2020 $128M Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-04
Q2 2020 $125M Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-05

BridgeBio Pharma, Inc. Annual Costs and Expenses (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $815M +$198M +32.1% Jan 1, 2024 Dec 31, 2024 10-K 2025-02-20
2023 $617M +$26.8M +4.55% Jan 1, 2023 Dec 31, 2023 10-K 2025-02-20
2022 $590M -$56.5M -8.74% Jan 1, 2022 Dec 31, 2022 10-K 2025-02-20
2021 $646M +$164M +33.9% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-22
2020 $483M +$176M +57.3% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-23
2019 $307M Jan 1, 2019 Dec 31, 2019 10-K 2022-02-25
* An asterisk sign (*) next to the value indicates that the value is likely invalid.